Q: Although monotherapy is usually used as the initial first-line treatment to begin anti-hypertensive treatment in newly diagnosed patients, combining which of the class with an AСЕ inhibitor may provide superior protection against cardiovascular events? - select one
A) Angiotensin receptor blocker (ARB)
B) Beta Blocker (BB)
C) Calcium channel blocker (CCB)
D) Тhiаziԁe or thiazidе-like diuretic
Answer: C
Patient choice plays a huge role when anti-hypertensive is started in a novice patient. Most patients prefer monotherapy. Initial classes preferred are:
- ΑСΕ inhibitor
- ΑRB
- Calcium channel blocker
- Тhiаziԁe or thiazidе-like diuretic
Data suggests that combining an AСЕ inhibitor and a (dihydropyridine) calcium channel blocker may provide superior protection against cardiovascular events. Although thiаziԁe diuretics are very popular, they don't offer such a benefit when combined with an ACE inhibitor.
BBs once considered the first line of drugs for initial anti-hypertensive management, have lost the privilege as they appear to be associated with inferior protection against stroke risk and all-cause mortality, particularly in patients with age over 60. Also, they are associated with impaired glucose tolerance and an increased risk of new-onset diabetes except for vasodilating BBs, i.e., such as carvedilol and nebivolol.
#cardiology
References:
* Due to date driven MCQ, we apologize for the long list of references
1. Thomopoulos C, Parati G, Zanchetti A. Effects of blood pressure-lowering treatment on cardiovascular outcomes and mortality: 14 - effects of different classes of antihypertensive drugs in older and younger patients: overview and meta-analysis. J Hypertens 2018; 36:1637.
2. Ettehad D, Emdin CA, Kiran A, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet 2016; 387:957.
3. Chen YJ, Li LJ, Tang WL, et al. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension. Cochrane Database Syst Rev 2018; 11:CD008170.
4. Blood Pressure Lowering Treatment Trialists' Collaboration, Turnbull F, Neal B, et al. Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials. BMJ 2008; 336:1121.
5. Jamerson K, Weber MA, Bakris GL, et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 2008; 359:2417.
6. Weber MA, Schiffrin EL, White WB, et al. Clinical practice guidelines for the management of hypertension in the community a statement by the American Society of Hypertension and the International Society of Hypertension. J Hypertens 2014; 32:3.
7. Messerli FH, Bangalore S, Julius S. Risk/benefit assessment of beta-blockers and diuretics precludes their use for first-line therapy in hypertension. Circulation 2008; 117:2706
8. Thomopoulos C, Bazoukis G, Tsioufis C, Mancia G. Beta-blockers in hypertension: overview and meta-analysis of randomized outcome trials. J Hypertens 2020; 38:1669.
9. Carlberg B, Samuelsson O, Lindholm LH. Atenolol in hypertension: is it a wise choice? Lancet 2004; 364:1684.
10. Khan N, McAlister FA. Re-examining the efficacy of beta-blockers for the treatment of hypertension: a meta-analysis. CMAJ 2006; 174:1737.
11. Messerli FH, Grossman E, Goldbourt U. Are beta-blockers efficacious as first-line therapy for hypertension in the elderly? A systematic review. JAMA 1998; 279:1903.
12. Bakris GL, Fonseca V, Katholi RE, et al. Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial. JAMA 2004; 292:2227.
13. Sarafidis PA, Bakris GL. Antihypertensive treatment with beta-blockers and the spectrum of glycaemic control. QJM 2006; 99:431.
14. Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, DePalma SM, Gidding S, Jamerson KA, Jones DW, MacLaughlin EJ, Muntner P, Ovbiagele B, Smith SC Jr, Spencer CC, Stafford RS, Taler SJ, Thomas RJ, Williams KA Sr, Williamson JD, Wright JT Jr. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018 Jun;71(6):1269-1324. doi: 10.1161/HYP.0000000000000066. Epub 2017 Nov 13. Erratum in: Hypertension. 2018 Jun;71(6):e136-e139. doi: 10.1161/HYP.0000000000000075. Erratum in: Hypertension. 2018 Sep;72(3):e33. doi: 10.1161/HYP.0000000000000080. PMID: 29133354.